Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides

US Patent 11332506 · Granted May 17, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Preventing and treating amyloid-beta deposition by stimulation of innate immunit2021
Specific murine and humanized monoclonal antibodies detecting pathology associat2020
Specific murine and humanized monoclonal antibodies detecting pathology associat2020
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal 2020
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2019
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2019
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2019
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2018
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2018
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2017
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2017
Method for treating amyloid disease2017